Single dose of vaccine provides strong protection against COVID-19: Abu Hilala

Jordan

Published: 2021-03-03 21:45

Last Updated: 2024-05-08 14:24


Single dose of vaccine provides strong protection against COVID-19: Abu Hilala
Single dose of vaccine provides strong protection against COVID-19: Abu Hilala

Wednesday, a member of the National Committee for Epidemics Munir Abu Hilala told Roya's Nabd Albalad that Jordan needs to focus during the coming period on vaccinating the largest possible number of elderly people.

He explained that a single dose of a coronavirus vaccine is enough to prevent the occurrence of moderate and severe COVID-19 symptoms.

Abu Hilala added that Jordan has the best scientifically and internationally proven medicines for treating COVID-19 patients. However, he warned against the misuse of medicines that may negatively affect the health of the patient.

He lastly talked about the health situation in the Kingdom, stressing that Jordan still needs a lot of time to achieve herd immunity.


Also Read: Jordan records 37 deaths and 5,335 new coronavirus cases


Tuesday, the government held a press conference to discuss the COVID-19 situation in the Kingdom and the national vaccination campaign.

Regarding the COVID-19 vaccines, the Minister of Health Nathir Obeidat stressed that providing coronavirus vaccines is 'extremely' difficult, adding that Jordan has made an agreement with Pfizer-BioNTech for 2.2 million doses of the vaccines, and an agreement with an undisclosed manufacturer for an additional 2.3 million doses.

Additionally, two million doses are set to arrive in the Kingdom through COVAX this month.

He added that 194,000 doses of the AstraZeneca vaccine are also set to arrive in Jordan soon.

Jordan will also receive an additional 41,000 doses next month through another undisclosed manufacturer.

The Director of the Coronavirus Crisis Cell Mazen Al-Faraya said that currently Jordan has the capacity to vaccinate 20,000 people.


Also Read: Friday lockdown reduces number of COVID-19 cases by 37 percent: Obeidat